Tag Archives: CELG

Top 10 Undervalued Stocks To Buy Right Now

Deutsche Bank’s Gregg Gilbert argues that shares of Endo International (ENDP) are “undervalued” despite “concerns aplenty.” He explains why:

Endo shares have been under significant pressure this year for a variety of reasons, including but not necessarily limited to soft generic trends in 4Q15/1Q16, earlier-than-expected generic competition to Voltaren Gel, product....More>>>

Celgene, NetEase Drop into Thursday’s 52-Week Low Club

May 17, 2018: Here are four stocks trading with heavy volume among 57 equities making new 52-week lows in Thursday’s session. On the NYSE advancers led decliners by about 1.12 to 1 and on the Nasdaq, advancers led decliners by about 1.5 to 1.

Celgene Corp. (NASDAQ: CELG) dropped about 2.7% Thursday to post a new 52-week low of $79.16. Shares closed at $81.36 on Wednesday and the stock’s....More>>>

Top China Stocks To Buy For 2018

The trade fight between the U.S. and China is starting to have an effect, but possibly not where President Donald Trump intended when he imposed extra tariffs on steel and aluminum imports.

Pork prices in Tokyo fell in April from a year earlier, and that subtracted 0.04 percentage point from inflation, one of the biggest causes of a weaker-than-expected price rise. China imposed extra 25....More>>>

Top Stocks To Own Right Now

Equities research analysts predict that MDC Partners (NASDAQ:MDCA) will post ($0.07) earnings per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for MDC Partners’ earnings, with the highest EPS estimate coming in at ($0.02) and the lowest estimate coming in at ($0.11). MDC Partners reported earnings per share of ($0.21) in the same....More>>>

Top 10 Heal Care Stocks To Buy For 2018

“Wanna get away?” The catchy Southwest Airlines Co (NYSE:LUV) slogan perfectly matches the mood at Tesla Inc (NASDAQ:TSLA). Long Wall Street’s poster child, TSLA stock is recently giving even the most hardened bulls some pause. Although company shares are up a meteoric 50% year-to-date, it has been less impressive after loosely flirting with the $400 mark.

Source: Shutterstock

Over....More>>>

3 Growth Stocks for In-the-Know Investors

In the same way that prioritizing growth typically means taking on more risk in pursuit of greater returns, investing in companies at early stages of their development means embracing greater uncertainty. More well-established growth stocks have their advantages — among them, a wider breadth of available business information and a tendency toward more-predictable performance — buta strict....More>>>

Big Biotechs Scare Off Short Sellers

The short interest data are out for the most recent settlement date, April 30. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, with big potential upside and big potential downside.

As we have said before, FDA rulings can make or break the biotech stocks, and short sellers and mega-bulls often go to war against each other in these companies.....More>>>

bluebird bio Looks for Data Ahead

bluebird bio (NASDAQ:BLUE) reportedfirst-quarter earnings last week, but like the biotech typically does, management didn’t hold a conference call, which makes the earnings release more of a rehash of the quarter than an actual update.

Bluebird results: The only number that really matters

Metric

Q1 2018

Q4 2017

Quarter-Over-Quarter Change

Cash,....More>>>

Top Medical Stocks To Watch For 2018

Westpac Banking Corp raised its stake in Edwards Lifesciences (NYSE:EW) by 22.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 67,689 shares of the medical research company’s stock after purchasing an additional 12,500 shares during the period. Westpac Banking Corp’s holdings in Edwards Lifesciences were worth $9,444,000 as of its most recent SEC....More>>>

Fridays Vital Data: Intel Corporation (INTC), NXP Semiconductors N.V. (NXPI) and Alibaba Group Ho

U.S. stock futures are trading broadly lower this morning. Wall Street was clearly anxious ahead of this morning’s April jobs report. Expectations were for a gain of 188,000 last month, on the heels of March’s surprisingly low 108,000 job adds.

Meanwhile, corporate earnings continue to chug along. Alibaba Group Holding Ltd (NYSE:BABA), Celgene Inc. (NASDAQ:CELG) and GoPro Inc.....More>>>